Quantum hybridization negative differential resistance from non-toxic halide perovskite nanowire heterojunctions and its strain control

无毒卤化物钙钛矿纳米线异质结的量子杂化负微分电阻及其应变控制

阅读:2

Abstract

While low-dimensional organometal halide perovskites are expected to open up new opportunities for a diverse range of device applications, like in their bulk counterparts, the toxicity of Pb-based halide perovskite materials is a significant concern that hinders their practical use. We recently predicted that lead triiodide (PbI(3)) columns derived from trimethylsulfonium (TMS) lead triiodide (CH(3))(3)SPbI(3) (TMSPbI(3)) by stripping off TMS ligands should be semimetallic, and additionally ultrahigh negative differential resistance (NDR) can arise from the heterojunction composed of a TMSPbI(3) channel sandwiched by PbI(3) electrodes. Herein, we computationally explore whether similar material and device characteristics can be obtained from other one-dimensional halide perovskites based on non-Pb metal elements, and in doing so deepen the understanding of their mechanistic origins. First, scanning through several candidate metal halide inorganic frameworks as well as their parental form halide perovskites, we find that the germanium triiodide (GeI(3)) column also assumes a semimetallic character by avoiding the Peierls distortion. Next, adopting the bundled nanowire GeI(3)-TMSGeI(3)-GeI(3) junction configuration, we obtain a drastically high peak current density and ultrahigh NDR at room temperature. Furthermore, the robustness and controllability of NDR signals from GeI(3)-TMSGeI(3)-GeI(3) devices under strain are revealed, establishing its potential for flexible electronics applications. It will be emphasized that, despite the performance metrics notably enhanced over those from the TMSPbI(3) case, these device characteristics still arise from the identical quantum hybridization NDR mechanism.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。